Stay updated on Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Sign up to get notified when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.

Latest updates to the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page
- Check5 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3, indicating a minor platform/template update reflected in the page metadata. It does not alter study details or visible content.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing the prior v3.6.0, indicating a small frontend update to the study page rendering.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRecruitment status was updated to indicate the study is no longer looking for participants, signaling that enrollment has ended. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a revision notice (Revision: v3.6.0) was added.SummaryDifference0.5%

- Check33 days agoChange DetectedThe page shows a new Revision tag v3.5.5, replacing the previous v3.5.4, representing a metadata update to the page. No substantive changes to the study data or eligibility criteria are indicated.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a small metadata update to the study record.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Publications section now references 'Anticoagulants for people hospitalised with COVID-19: a rapid review' as the source, updating the wording of the cited Cochrane review. This reflects a bibliographic clarification rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.